Found: 105
Select item for more details and to access through your institution.
Price variability of TNF‐α inhibitor biosimilars among European countries.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 8, p. e663, doi. 10.1111/jdv.19756
- By:
- Publication type:
- Article
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
The prevalence of skin diseases in Greece, impact on quality of life and stigmatization: A population‐based survey study.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 2, p. 591, doi. 10.1002/jvc2.287
- By:
- Publication type:
- Article
Peer review, scientific publishing and the law of reciprocity.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 6, p. 988, doi. 10.1111/jdv.20024
- By:
- Publication type:
- Article
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials.
- Published in:
- British Journal of Dermatology, 2024, v. 190, n. 5, p. 668, doi. 10.1093/bjd/ljae014
- By:
- Publication type:
- Article
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 2, p. 299, doi. 10.1007/s40257-024-00846-3
- By:
- Publication type:
- Article
Changing the lives of patients with skin diseases—The JEADV's motto.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 3, p. 444, doi. 10.1111/jdv.19791
- By:
- Publication type:
- Article
The vIGA‐AD scale for atopic dermatitis: Uptake in the past 5 years and position of the International Eczema Council.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 3, p. e291, doi. 10.1111/jdv.19627
- By:
- Publication type:
- Article
Efficacy and Safety of Topical Tacrolimus Microemulsion Applied Twice Daily in Patients with Mild to Moderate Scalp Psoriasis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 2, p. 521, doi. 10.1007/s13555-024-01102-6
- By:
- Publication type:
- Article
IL-4Rα Inhibition for Severe “Eosinophilic Gastroenteritis, Allergy, and Anaphylaxis” Syndrome due to a Gain-of-Function Variant in STAT6.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Freedom from disease in plaque psoriasis: Comparing the perceived importance of voting round 2 statements from a Delphi consensus of patients, physicians and nurses.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 1, p. e16, doi. 10.1111/jdv.19397
- By:
- Publication type:
- Article
Clinical features, therapeutic choice and response by phototype in psoriasis: analysis of the French PsoBioTeq cohort.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 11, p. 1238, doi. 10.1093/ced/llad233
- By:
- Publication type:
- Article
Ethnicity and skin conditions in Europe: A large survey from the "burden of skin diseases" EADV project.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 11, p. e1356, doi. 10.1111/jdv.18994
- By:
- Publication type:
- Article
The burden of skin disease in Europe.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, p. 3, doi. 10.1111/jdv.19390
- By:
- Publication type:
- Article
Quality of life and stigmatization in people with skin diseases in Europe: A large survey from the 'burden of skin diseases' EADV project.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, p. 6, doi. 10.1111/jdv.18917
- By:
- Publication type:
- Article
The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, p. 17, doi. 10.1111/jdv.18916
- By:
- Publication type:
- Article
Public perception of dermatologists in Europe: Results from a population-based survey.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, p. 27, doi. 10.1111/jdv.18988
- By:
- Publication type:
- Article
Impact of chronic prurigo nodularis on daily life and stigmatization.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 7, p. e908, doi. 10.1111/jdv.19013
- By:
- Publication type:
- Article
436 Nemolizumab monotherapy was associated with significant improvements in prurigo activity score in adult patients with moderate-to-severe prurigo nodularis: results from a phase 3 trial (OLYMPIA 2).
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.056
- By:
- Publication type:
- Article
Bimekizumab maintenance of response through 3 years in patients with moderate-to-severe plaque psoriasis: results from the BE BRIGHT open-label extension trial.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 6, p. 749, doi. 10.1093/bjd/ljad035
- By:
- Publication type:
- Article
Out‐of‐pocket expenditures in adult patients with prurigo nodularis in France.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 2, p. 392, doi. 10.1002/jvc2.121
- By:
- Publication type:
- Article
Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 981, doi. 10.1007/s13555-023-00897-0
- By:
- Publication type:
- Article
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 2, p. 198, doi. 10.1093/bjd/ljac040
- By:
- Publication type:
- Article
IgA vasculitis following COVID-19 vaccination: A French multicentre case series including 12 patients.
- Published in:
- Journal of Rheumatology, 2023, v. 50, n. 2, p. 252, doi. 10.3899/jrheum.220545
- By:
- Publication type:
- Article
Patient Unique Stigmatization Holistic tool in dermatology (PUSH‐D): Development and validation of a dermatology‐specific stigmatization assessment tool.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 2, p. 443, doi. 10.1111/jdv.18641
- By:
- Publication type:
- Article
Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq Registry.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 1, p. 150, doi. 10.1093/bjd/ljac024
- By:
- Publication type:
- Article
Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 11, p. 2087, doi. 10.1111/jdv.18376
- By:
- Publication type:
- Article
Longer dupilumab dosing intervals in adult patients with atopic dermatitis: experience from a French multicentre retrospective cohort study.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 4, p. 602, doi. 10.1111/bjd.21628
- By:
- Publication type:
- Article
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate‐to‐severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo‐controlled, phase III clinical trial (BREEZE‐AD4)*
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 3, p. 338, doi. 10.1111/bjd.21630
- By:
- Publication type:
- Article
Severe pemphigoid nodularis successfully treated with dupilumab.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 9, p. 1, doi. 10.1111/dth.15727
- By:
- Publication type:
- Article
Midostaurin‐induced lichenoid photoallergic reaction in a patient with systemic mastocytosis.
- Published in:
- Photodermatology, Photoimmunology & Photomedicine, 2022, v. 38, n. 5, p. 511, doi. 10.1111/phpp.12778
- By:
- Publication type:
- Article
Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 433, doi. 10.1007/s40257-022-00679-y
- By:
- Publication type:
- Article
A Multicentre Randomised Controlled Study Evaluating the Effect of a Standardised Education Programme on Quality of Life, Disease Severity, and Disease Knowledge in Patients with Moderate-To-Severe Psoriasis: The EDUPSO Study.
- Published in:
- Dermatology (10188665), 2022, v. 238, n. 4, p. 630, doi. 10.1159/000520289
- By:
- Publication type:
- Article
Dupilumab-Associated Adverse Events During Treatment of Allergic Diseases.
- Published in:
- Clinical Reviews in Allergy & Immunology, 2022, v. 62, n. 3, p. 519, doi. 10.1007/s12016-022-08934-0
- By:
- Publication type:
- Article
Bullous pemphigoid associated with Grover disease: a specific toxicity of anti‐PD‐1 therapies?
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 6, p. e200, doi. 10.1111/ijd.16068
- By:
- Publication type:
- Article
The biological basis of disease recurrence in psoriasis: a historical perspective and current models.
- Published in:
- British Journal of Dermatology, 2022, v. 186, n. 5, p. 773, doi. 10.1111/bjd.20963
- By:
- Publication type:
- Article
A nationwide study evaluating the association of autoimmune bullous diseases and acquired haemophilia: description of clinical and prognostic features.
- Published in:
- British Journal of Dermatology, 2022, v. 186, n. 5, p. 899, doi. 10.1111/bjd.20953
- By:
- Publication type:
- Article
Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v101.566
- By:
- Publication type:
- Article
Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.1984
- By:
- Publication type:
- Article
Impact of Childhood Onset Psoriasis on Addictive Behaviours, Socioeconomic and Educational Data in Adulthood.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.2484
- By:
- Publication type:
- Article
Safety of Brodalumab in Plaque Psoriasis: Integrated Pooled Data from Five Clinical Trials.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.1993
- By:
- Publication type:
- Article
Severe Vulvar and Perianal Crohn's Disease: A Case Report and Review of the Literature.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 1, p. 61, doi. 10.1007/s13555-021-00635-4
- By:
- Publication type:
- Article
Correction to: Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort Psobioteq.
- Published in:
- Dermatology (10188665), 2021, v. 237, n. 3, p. 338, doi. 10.1159/000513398
- By:
- Publication type:
- Article
Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus.
- Published in:
- Pediatric Allergy & Immunology, 2021, v. 32, n. 3, p. 414, doi. 10.1111/pai.13422
- By:
- Publication type:
- Article
Neuropsychiatric, cognitive and sexual impairment in mastocytosis patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Use of Complementary and Alternative Medicines by Patients with Psoriasis: Results from a Study with 2562 Patients.
- Published in:
- 2021
- By:
- Publication type:
- Letter
How to assess patient satisfaction regarding physician interaction: A systematic review.
- Published in:
- Dermatologic Therapy, 2021, v. 34, n. 2, p. 1, doi. 10.1111/dth.14702
- By:
- Publication type:
- Article
How Oral Specialists Can Help Diagnose and Manage Extra-Digestive Inflammatory Bowel Disease Complications.
- Published in:
- Case Reports in Gastroenterology, 2021, v. 15, n. 1, p. 276, doi. 10.1159/000513156
- By:
- Publication type:
- Article